Cholesdrop
Cholesdrop, licence 80087010: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nutri bio Pharma Inc. / Inov Pharma
- NPN or DIN-HM
- 80087010
- Status
- Active licence
- Licence date
- 11 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 60 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Policosanol Source : Oryza sativa - cire (fruit) | 5.0 milligramme | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 15.0 milligramme | 60,000 µg |
| Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose Source : Chitine | 400.0 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Aide à diminuer le niveau de cholestérol sanguin total (et LDL). Aide à maintenir des niveaux de cholestérol sains. Antioxydant pour le maintien d'une bonne santé. Source d'acides gras essentiels pour le maintien d'une bonne santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vois etes enceinte ou allaitez, consulter un praticien de soins de santé avant d'en faire l'usage. Si vous prenez des anticoagulants (p.ex.Coumaphene ou Warfarine) ou des médicaments anti-plaquettaires (p.ex.AAS), consulter un praticien de soins de santé avant d'en faire l'usage.
- Contre-indications
Si vous etes allergique aux fruits de mer, ne pas utiliser ce produit.
- Effets indésirables connus
Peut causer des douleurs abdominales, des ballonnements, de la constipation, de l'indigestion, et/ou de la diarhée.
Source
Official Health Canada record, licence 80087010
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.